Results 151 to 160 of about 2,285,787 (260)

A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. [PDF]

Med Sci Monit
Lv X, Chen X, Ge Y, Si G, Li Y, Li X, Yuan X.   +6 more
europepmc   +1 more source

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells. [PDF]

Bone Marrow Transplant
Krauß SM, Weibl K, Bach E, Brückner M, Weigert A, Tumewu T, Ruschpler E, Vogtmann G, Hoffmann S, Penack O, Janz M, Buhmann R, Henschler R, Bullinger L, Keller U, Schwind S, Merz M, Jentzsch M, Franke GN, Herling M, Platzbecker U, Metzeler KH, Vučinić V.   +22 more
europepmc   +1 more source

Chimeric antigen receptor (CAR)-T cell therapy for solid tumors in pediatric patients: current breakthroughs, dilemmas, and strategies. [PDF]

Exp Hematol Oncol
Mai Y, Wang Z, Wang J, Song M, Xiang T, He Y, Chang AH, Zhang Y.   +7 more
europepmc   +1 more source

Editorial: Novel chimeric antigen receptor (CAR) designs in engineering NK cells for cancer. [PDF]

Front Immunol
Chan WK.
europepmc   +1 more source

Determinants of Chimeric Antigen Receptor (CAR) T Cell Success: In Vitro and In Vivo Preclinical Assessment. [PDF]

Cancers (Basel)
Sheng MK, Murphy WJ.
europepmc   +1 more source

HLA-Haploidentical Anti-CD7 Chimeric Antigen Receptor (CAR) T Cells for Transplant-Naïve Patients With Refractory T-Cell Acute Lymphoblastic Leukemia. [PDF]

Am J Hematol
Becilli M, Del Bufalo F, Merli P, Rosignoli C, Algeri M, Gunetti M, Pagliara D, Quagliarella F, Boccieri E, Mandelli B, Bertaina V, Cefalo MG, Agrati C, Sinibaldi M, Iaffaldano L, De Angelis B, Quintarelli C, Locatelli F.   +17 more
europepmc   +1 more source

Humanized Chimeric Antigen Receptor (CAR) T cells [PDF]

Journal of Cancer Immunology, 2021
openaire   +1 more source

Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders. [PDF]

Cells
Ciosek A, Hofmann J, Galant K, Marinkovich MP, Wierzbowska A, Ciążyńska M, Bień N, Narbutt J, Lesiak A.   +8 more
europepmc   +1 more source

Involvement of the hospital pharmacist in securing the chimeric antigen receptor (CAR)-T cell circuit. [PDF]

Eur J Hosp Pharm
Bryla A, Lorent S, Vervacke A, Scolas G, Alexandre L.   +4 more
europepmc   +1 more source

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer. [PDF]

Nat Biomed Eng
Chen GM, Jain A, Gering DT, Satulovsky J, Datta S, Lai P, Karar J, Gonzalez VE, Alexander K, Chew A, Jadlowsky JK, Ruella M, Paruzzo L, Amses KR, Rech AJ, Stadtmauer EA, Frey NV, Hexner EO, Porter DL, Cohen AD, Gill SI, Garfall AL, Schuster SJ, Mo KC, Liang SI, Spasic M, Levine BL, Siegel DL, Ramírez-Fernández A, Cabanski CR, Yang E, Mackall CL, Bushman FD, Good Z, John Wherry E, June CH, Fraietta JA.   +36 more
europepmc   +1 more source